SCHEMBL6320139

SCHEMBL6320139

COc1ccc2cc(C(CNc3cnc4ccccc4c3)P3(=O)OCCO3)sc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 5/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CNR2 P34972 1/20 0.39
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 5/20 0.38
GAA P10253 4/20 0.38
RAB9A P51151 3/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
HTT P42858 3/20 0.38
NPC1 O15118 2/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
FAAH O00519 2/20 0.37
IGF1R P08069 3/20 0.36
KMT2A Q03164 3/20 0.36
FLT1 P17948 1/20 0.34
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317959 0.92 ALPL (0.38) ALPLLMNASMN1; SMN2CNR2KDM4E
SCHEMBL6316811 0.77 LMNA (0.40) ALPLLMNASMN1; SMN2CNR2KDM4E
SCHEMBL6325319 0.73 KDR (0.44) LMNASMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL6326060 0.70 ABL1 (0.33) RAB9AMAPTNPC1KMT2A
SCHEMBL6320852 0.68 TDP2 (0.37) LMNASMN1; SMN2KDM4EALDH1A1RAB9A
SCHEMBL6317568 0.67 CA2 (0.36) LMNASMN1; SMN2KDM4EALDH1A1RAB9A
SCHEMBL6318666 0.66 LMNA (0.46) ALPLLMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL6317386 0.66 HDAC6 (0.37) LMNASMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL6318067 0.65 CA2 (0.34)
SCHEMBL28048000 0.65 PDGFRB (0.61) ALPLLMNASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US claimed
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL ALPL 425/4885LMNA 144/4885SMN1; SMN2 4738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.